New Age Alpha Advisors LLC Has $3.40 Million Position in Tenet Healthcare Corporation $THC

New Age Alpha Advisors LLC lowered its stake in shares of Tenet Healthcare Corporation (NYSE:THC) by 57.2% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 17,130 shares of the company’s stock after selling 22,880 shares during the period. New Age Alpha Advisors LLC’s holdings in Tenet Healthcare were worth $3,404,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of THC. NewEdge Advisors LLC boosted its stake in shares of Tenet Healthcare by 6.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock valued at $389,000 after buying an additional 166 shares during the period. Jones Financial Companies Lllp boosted its stake in shares of Tenet Healthcare by 299.1% during the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after buying an additional 1,274 shares during the period. Sivia Capital Partners LLC acquired a new stake in shares of Tenet Healthcare during the 2nd quarter valued at $290,000. Quantbot Technologies LP acquired a new stake in shares of Tenet Healthcare during the 2nd quarter valued at $65,000. Finally, Amundi boosted its stake in shares of Tenet Healthcare by 4,207.8% during the 2nd quarter. Amundi now owns 27,010 shares of the company’s stock valued at $4,652,000 after buying an additional 26,383 shares during the period. Institutional investors and hedge funds own 95.44% of the company’s stock.

Insider Buying and Selling

In related news, insider R. Scott Ramsey sold 8,017 shares of Tenet Healthcare stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $232.70, for a total value of $1,865,555.90. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Thomas W. Arnst sold 24,000 shares of Tenet Healthcare stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the completion of the transaction, the executive vice president owned 8,012 shares in the company, valued at $1,875,128.48. This trade represents a 74.97% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 46,517 shares of company stock worth $10,943,111 in the last quarter. 0.97% of the stock is currently owned by company insiders.

Tenet Healthcare Stock Performance

Shares of THC opened at $174.00 on Tuesday. The company has a market capitalization of $14.99 billion, a PE ratio of 9.05, a price-to-earnings-growth ratio of 1.14 and a beta of 1.30. Tenet Healthcare Corporation has a one year low of $146.60 and a one year high of $247.21. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. The company’s fifty day moving average price is $193.06 and its 200 day moving average price is $202.66.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping the consensus estimate of $4.21 by $0.61. The firm had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business’s quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the firm posted $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, analysts expect that Tenet Healthcare Corporation will post 17.67 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on THC shares. Barclays decreased their target price on shares of Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating for the company in a research note on Tuesday, May 5th. KeyCorp reduced their price objective on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Tenet Healthcare in a research note on Friday, March 27th. Jefferies Financial Group lifted their price objective on shares of Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a research note on Thursday, February 12th. Finally, TD Cowen reaffirmed a “buy” rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. Nineteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $244.16.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.